NASDAQ · BYAH

Park Ha Biological Technology Co. news

$2.43+0.83%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days9English, de-duplicated
Positive00% of coverage
Neutral00%
Negative9100% of coverage

About Park Ha Biological Technology Co.

PHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH
GlobeNewswire Inc.Sep 23, 10:44 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, materially false statements, undisclosed trading manipulation, and artificially structured IPO designed to enable market manipulation. These serious allegations of fraud and deception warrant a negative sentiment.

PHH, BYAH FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH
GlobeNewswire Inc.Sep 20, 7:07 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, false and misleading statements, undisclosed material facts, and intentional manipulation of stock price through artificially low public float structure. These serious allegations of fraud and deception warrant a negative sentiment.

PHH, BYAH DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
GlobeNewswire Inc.Sep 9, 5:32 PM ET▼ Negative

Company is subject to securities class action lawsuit alleging fraudulent stock promotion scheme, false statements, misleading risk disclosures, and artificially manipulated trading activity with intentionally low public float to enable manipulation.

PHH, BYAH FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
GlobeNewswire Inc.Sep 6, 5:35 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, false statements, misleading disclosures, market manipulation through artificially low public float, and social media-based misinformation. These serious allegations of fraud and deception warrant a negative sentiment.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
GlobeNewswire Inc.Aug 7, 6:37 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, social media-based misinformation, impersonated financial professionals, artificially manipulated trading activity, and intentionally structured IPO with extremely low public float to enable manipulation. Defendants are accused of making materially false statements and failing to disclose material adverse facts.

BYAH Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Park Ha Biological Technology Co., Ltd. Class Action
GlobeNewswire Inc.Jul 31, 8:23 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging market manipulation, fraudulent promotion, and failure to disclose material risks. The stock experienced a catastrophic 93% single-day collapse, resulting in over $1 billion in market value destruction, indicating severe corporate governance failures and investor harm.

Park Ha Biological Technology (BYAH) Stock Surges Over 41% After Hours: Why Is It Moving?
BenzingaJun 18, 12:27 AM ETNeutral

While the stock surged 41.66% after-hours following a $2M direct offering and AI partnership announcement, the company has lost 99.89% of its value over 12 months and trades near annual lows. The after-hours spike appears driven by technical factors rather than fundamental strength, and the article emphasizes 'elevated risk' and need for 'clearer signs of recovery,' suggesting cautious optimism at best.

Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering
GlobeNewswire Inc.Jun 12, 2:54 PM ETNeutral

The company is conducting a capital raise through a registered direct offering, which is a standard financing activity. While capital raises can indicate growth plans or operational needs, the announcement itself is factual and routine. The use of proceeds for 'general corporate and working capital purposes' is non-specific and does not indicate exceptional growth prospects or concerning financial distress.

Why Is Park Ha Biological Technology Rocketing On Friday?
BenzingaJun 12, 10:47 AM ET▲ Positive

The company announced a strategic partnership with Star Plus Action that enhances its capabilities in product development and digital innovation. The partnership focuses on AI-integrated skincare services, positioning the company to meet growing consumer demand. The stock price surged 133%, reflecting strong investor optimism about accelerated growth prospects.

Also mentions BYAH

Articles that tag BYAH but are mainly about other companies.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology